全文获取类型
收费全文 | 1536篇 |
免费 | 101篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 105篇 |
妇产科学 | 51篇 |
基础医学 | 168篇 |
口腔科学 | 36篇 |
临床医学 | 128篇 |
内科学 | 431篇 |
皮肤病学 | 36篇 |
神经病学 | 86篇 |
特种医学 | 155篇 |
外科学 | 201篇 |
综合类 | 16篇 |
预防医学 | 107篇 |
眼科学 | 17篇 |
药学 | 52篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 34篇 |
出版年
2022年 | 9篇 |
2021年 | 28篇 |
2020年 | 21篇 |
2019年 | 28篇 |
2018年 | 37篇 |
2017年 | 29篇 |
2016年 | 31篇 |
2015年 | 33篇 |
2014年 | 50篇 |
2013年 | 52篇 |
2012年 | 66篇 |
2011年 | 69篇 |
2010年 | 57篇 |
2009年 | 55篇 |
2008年 | 69篇 |
2007年 | 68篇 |
2006年 | 73篇 |
2005年 | 52篇 |
2004年 | 47篇 |
2003年 | 45篇 |
2002年 | 52篇 |
2001年 | 49篇 |
2000年 | 46篇 |
1999年 | 39篇 |
1998年 | 43篇 |
1997年 | 30篇 |
1996年 | 45篇 |
1995年 | 45篇 |
1994年 | 36篇 |
1993年 | 21篇 |
1992年 | 19篇 |
1991年 | 29篇 |
1990年 | 18篇 |
1989年 | 33篇 |
1988年 | 35篇 |
1987年 | 27篇 |
1986年 | 24篇 |
1985年 | 21篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 6篇 |
1981年 | 7篇 |
1980年 | 11篇 |
1978年 | 5篇 |
1977年 | 11篇 |
1976年 | 5篇 |
1975年 | 5篇 |
1968年 | 5篇 |
1967年 | 8篇 |
1966年 | 7篇 |
排序方式: 共有1649条查询结果,搜索用时 0 毫秒
1.
2.
3.
P. Moya E. Baixeras I. Barasoain J. M. Rojo E. Ronda M. L. Alonso A. Portol s 《Immunopharmacology and immunotoxicology》1987,9(2):243-256
The “in vivo” effect of Inmunoferon (AM3) on the production of interferon (IFN) and natural killer (NK) activity in young and old mice was studied. Although AM3 is not an IFN inducer by itself, enhancements in the serum IFN levels were produced when drug was associated to Newcastle disease virus or bacterial lipopo-lysaccharides as IFN inducers. This effect appeared to be dependent on the time lapsed between the inducer agent and drug. In addition, a significant stimulating effect on NK cell activity was also produced by AM3 treatments. This effect could be a consequence of a marked IFN induction and/or a modifying effect in prostaglandin synthesis. 相似文献
4.
5.
Intestinal schistosomiasis japonica: CT-pathologic correlation 总被引:1,自引:0,他引:1
Lee RC; Chiang JH; Chou YH; Rubesin SE; Wu HP; Jeng WC; Hsu CC; Tiu CM; Chang T 《Radiology》1994,193(2):539
6.
M Ballester D Obrador I Carrió C Moya J M Augè R Bordes V Martí I Bosch L Bernà-Roqueta M Estorch 《Circulation》1992,85(1):61-68
BACKGROUND. Detection and treatment for rejection after transplantation are based on the identification of myocyte damage upon endomyocardial biopsy. Noninvasive detection of such damage is possible with 111In-labeled monoclonal antimyosin antibodies (MAA). Although the presence and degree of MAA uptake parallels the rejection activity detected by biopsy, the relation between the degree of uptake and the occurrence of severe rejection-related complications has not been previously assessed. METHODS AND RESULTS. Two hundred forty-seven MAA studies were performed coinciding with biopsies in 52 patients 1-71 months after transplantation. A heart-to-lung ratio (HLR) was used as a measure of relative MAA uptake, with an HLR of 1.55 discriminating normal from abnormal studies. Of the 247 antimyosin studies, 149 coincided with absent, 38 with mild, and 60 with moderate rejection at biopsy. HLR was 1.68 +/- 0.27, 1.79 +/- 0.22, and 1.91 +/- 0.33 in the three biopsy groups, respectively (p less than 0.0001). Two hundred thirty-eight of 247 antimyosin studies coexisted with absent rejection-related complications; in nine of 247 patients, such complications were detected (five congestive heart failure episodes due to rejection and four episodes of vascular occlusion, which resulted in five deaths), and mean HLR was 1.74 +/- 0.3 and 2.1 +/- 0.16 in the two groups, respectively (p less than 0.0001). No complications were noted in 193 studies of patients with HLR of less than 2.00, whereas in nine of 45 with HRL of 2.00 or greater, complications occurred (p less than 0.0001). None of the 23 patients prospectively followed since surgery who had a gradual decrease in MAA uptake during the first 3 months showed rejection-related complications, whereas persistent uptake was associated with complications in five of nine patients (p less than 0.001). CONCLUSIONS. No rejection-related complications are seen coinciding with HLR of less than 2.00, whereas patients who have complications have an HLR of more than 2.00. The early 3-month pattern of decreasing MAA uptake is associated with a clinical course free of rejection-related complications, whereas a persistent pattern is a signal of the possibility of such complications. 相似文献
7.
BACKGROUND—The clinical significance of thepresence of non-tuberculous mycobacteria in the sputum of patients withcystic fibrosis is unclear. A retrospective case-control study wasperformed to assess possible risk factors for non-tuberculousmycobacteria and its impact on clinical status in patients with cystic fibrosis.
METHODS—The records of all patients attending theLeeds cystic fibrosis clinics who were positive for non-tuberculousmycobacteria were examined. Each case was matched with two controls forsex, age, and respiratory function at the time of the firstnon-tuberculous mycobacteria isolate. Details of respiratory function,nutritional status, antibiotic and corticosteroid therapy,Shwachman-Kulczycki (S-K) score, Northern chest radiographic score, andthe frequency of isolation of other bacteria and fungi were collectedfrom two years before to two years after the first non-tuberculousmycobacteria isolate. The patients' genotype and the presence ofdiabetes mellitus were also recorded.
RESULTS—Non-tuberculous mycobacteria were isolatedfrom 14 patients out of a cystic fibrosis population of 372 (prevalence = 3.8%). No significant effect of non-tuberculous mycobacteria wasseen on respiratory function, nutritional status, or S-K score. There was a significant association with the number of intravenous antibiotic courses received before the first isolate with cases receiving, onaverage, twice as many courses as controls (cases 6.64, controls 2.86, 95% CI for difference 1.7 to 5.9). No significant difference was seenbetween cases and controls for Northern scores, previous steroidtherapy, or the incidence of diabetes mellitus.
CONCLUSIONS—Non-tuberculous mycobacteria infectionin patients with cystic fibrosis is uncommon and its clinical impactappears to be minimal over a two year period. Frequent intravenousantibiotic usage is a possible risk factor for colonisation withnon-tuberculous mycobacteria.
相似文献
METHODS—The records of all patients attending theLeeds cystic fibrosis clinics who were positive for non-tuberculousmycobacteria were examined. Each case was matched with two controls forsex, age, and respiratory function at the time of the firstnon-tuberculous mycobacteria isolate. Details of respiratory function,nutritional status, antibiotic and corticosteroid therapy,Shwachman-Kulczycki (S-K) score, Northern chest radiographic score, andthe frequency of isolation of other bacteria and fungi were collectedfrom two years before to two years after the first non-tuberculousmycobacteria isolate. The patients' genotype and the presence ofdiabetes mellitus were also recorded.
RESULTS—Non-tuberculous mycobacteria were isolatedfrom 14 patients out of a cystic fibrosis population of 372 (prevalence = 3.8%). No significant effect of non-tuberculous mycobacteria wasseen on respiratory function, nutritional status, or S-K score. There was a significant association with the number of intravenous antibiotic courses received before the first isolate with cases receiving, onaverage, twice as many courses as controls (cases 6.64, controls 2.86, 95% CI for difference 1.7 to 5.9). No significant difference was seenbetween cases and controls for Northern scores, previous steroidtherapy, or the incidence of diabetes mellitus.
CONCLUSIONS—Non-tuberculous mycobacteria infectionin patients with cystic fibrosis is uncommon and its clinical impactappears to be minimal over a two year period. Frequent intravenousantibiotic usage is a possible risk factor for colonisation withnon-tuberculous mycobacteria.
相似文献
8.
Two types of neutralisation or blocking test using human anti-HBs are described for the confirmation of positive results obtained by immunoradiometric screening for HBSAg. 相似文献
9.
George Capone Mary Stephens Stephanie Santoro Brian Chicoine Peter Bulova Moya Peterson Joan Jasien Anna Jo Smith Down Syndrome Medical Interest Group Adult Health Workgroup 《American journal of medical genetics. Part A》2020,182(7):1832-1845
Adults with Down syndrome (DS) represent a unique population who are in need of clinical guidelines to address their medical care. Many of these conditions are of public health importance with the potential to develop screening recommendations to improve clinical care for this population. Our workgroup previously identified and prioritized co‐occurring medical conditions in adults with DS. In this study, we again performed detailed literature searches on an additional six medical conditions of clinical importance. A series of key questions (KQ) were formulated a priori to guide the literature search strategy. Our KQs focused on disease prevalence, severity, risk‐factors, methodologies for screening/evaluation, impact on morbidity, and potential costs/benefits. The available evidence was extracted, evaluated and graded on quality. The number of participants and the design of clinical studies varied by condition and were often inadequate for answering most of the KQ. Based upon our review, we provide a summary of the findings on hip dysplasia, menopause, acquired cardiac valve disease, type 2 diabetes mellitus, hematologic disorders, and dysphagia. Minimal evidence demonstrates significant gaps in our clinical knowledge that compromises clinical decision‐making and management of these medically complex individuals. The creation of evidence‐based clinical guidance for this population will not be possible until these gaps are addressed. 相似文献
10.
Detection of chromosomes and estimation of aneuploidy in human spermatozoa using fluorescence in-situ hybridization 总被引:11,自引:0,他引:11
The development and application of fluorescence in-situ hybridization
(FISH) has opened the way for comprehensive studies on numerical chromosome
abnormalities in human spermatozoa. FISH can be rapidly applied to large
numbers of spermatozoa and thus overcomes the major limitation of
karyotyping spermatozoa after penetration of zona-free hamster oocytes. The
simultaneous hybridization of two or more chromosome-specific probes to
spermatozoa and subsequent detection of the bound probes using different
fluorescent detection systems enables two or more chromosomes to be
localized simultaneously in the same spermatozoon and provides a technique
for undertaking reasonable estimates of aneuploidy. The most commonly used
probes are those which bind to the centromeric region of specific
chromosomes. Most studies to date have concentrated on estimating
aneuploidy in spermatozoa from normospermic men, although reports are
beginning to appear on aneuploidy in spermatozoa from subfertile and
infertile men. Multi- probe FISH studies have generally reported disomy
(hyperhaploidy) estimates of 0.05-0.2% per chromosome. There is preliminary
evidence that some chromosomes such as X, Y and 21 are predisposed towards
higher rates of non-disjunction during spermatogenesis. There are also
suggestions of inter-donor variability in aneuploidy frequencies for
specific chromosomes, although this requires confirmation in larger
studies. While FISH is clearly a powerful technique that has many
applications in reproductive medicine, it must also be realized that it
does have limitations and the technology itself is still evolving and has
yet to be fully validated on spermatozoa.
相似文献